Frederick R. Manby
CIK: 0002156015
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)1 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
IAM
Iambic Therapeutics, Inc.
DirectorOfficer
Discretionary Trading P&L
Holdings
About Manby Frederick R
Manby Frederick R (SEC CIK 0002156015) files insider reports with the SEC as Chief Technology Officer of Iambic Therapeutics, Inc. (IAM).
Signal8 holds 2 ownership filings by Manby Frederick R (1 Form 3, 1 Form 4), filed between Oct 14, 2026 and Oct 16, 2026. Those filings report 1 transaction, the latest on Oct 14, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Manby Frederick R's filings is in SAN DIEGO, CA.
Recent filings by Manby Frederick R
- Oct 14, 2026: Grant or award of IAM shares (Form 4, code A).
Other insiders filing for Iambic Therapeutics, Inc. (IAM)
- Catalio Capital Management, LP, 10% Owner
- Vogelstein R Jacob, Director
- Secora Michael, CFO & Chief Corp Dev Ofcr
- RASTETTER WILLIAM H, Director
- Rachlin Evan Lockwood, Director
- EMSTER KURT VON, Director